| NAME |
LAMIVUDINE 25MG/5ML SOLN,ORAL |
| VA GENERIC NAME |
LAMIVUDINE |
| DOSAGE FORM |
SOLN,ORAL |
| FORMULARY DESIGNATOR |
PA-F |
| FORMULARY DESIGNATOR TEXT |
Restricted to ID (HIV/HBV) or GI, Oncology, Rheumatology for HBV (or facility designated/authorized provider)
|
| ACTIVE INGREDIENTS |
|
| NATIONAL FORMULARY INDICATOR |
YES |
| NATIONAL FORMULARY RESTRICTION |
Refer to HIV/AIDS TAG treatment guidelines
|
| CS FEDERAL SCHEDULE |
Unscheduled |
| STRENGTH |
25 |
| SINGLE/MULTI SOURCE PRODUCT |
Single source |
| UNITS |
MG/5ML |
| NATIONAL FORMULARY NAME |
LAMIVUDINE SOLN,ORAL |
| CREATE DEFAULT POSSIBLE DOSAGE |
NO |
| POSSIBLE DOSAGES TO CREATE |
No Possible Dosages |
| CODING SYSTEM |
|
| COPAY TIER |
-
- COPAY TIER LEVEL: 2
- COPAY EFFECTIVE DATE: 2017-02-27 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
LAMIVUDINE 25MG/5ML ORAL SOLN |
| VA PRODUCT IDENTIFIER |
L0212 |
| TRANSMIT TO CMOP |
NO |
| VA DISPENSE UNIT |
ML |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4013355 |
| EFFECTIVE DATE/TIME |
-
- 2005-03-10 00:00:00
- STATUS: ACTIVE
|
